vimarsana.com
  1. Home
  2. Live Updates
  3. Transcend Nhl 001 - Breaking News

Latest Breaking News On - Transcend nhl 001 - Page 1 : vimarsana.com

Lisocabtagene Maraleucel in R/R MCL: Primary Analysis Results from the MCL Cohort of the Single-Arm, Multicenter, Seamless Design TRANSCEND NHL 001 Study

Alexey Danilov, MD, PhD, reviews data from the TRANSCEND NHL 001 study investigating lisocabtagene maraleucel in patients with relapsed/refractory mantle cell lymphoma.

Alexey danilovLisocabtagene maraleucelInternational conference on malignant lymphomaPrimary analysis resultsSeamless designPartnership withInternational conferenceMalignant lymphomaTranscend nhl 001Relapsed refractory mantle cell lymphomaLiso celRelapsed refractory mclMantle cell lymphomaTranscend nhl 001 studyRr mclTranscend nhl 001 results

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.